Unknown molecular targets involved in cell proliferation and angiogenesis

The phrase "Unknown molecular targets involved in cell proliferation and angiogenesis" is nonspecific and does not correspond to a particular molecule, receptor, enzyme, or other defined therapeutic target. In scientific and clinical contexts, key molecules promoting cell proliferation and angiogenesis are often precisely named (such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), fibroblast growth factor (FGF), and various matrix metalloproteinases (MMPs)), each with known biological functions, molecular classifications, disease associations (such as cancer and wound healing), and existing therapeutic agents[1][2][3][4][5][6]. A generic or "unknown" label does not provide sufficient information for structured cataloging, biomarker association, drug interaction listing, or targeted pharmacological intervention and should be replaced with identified, scientifically validated molecular entities. This entry is **incorrect** for scientific, pharmaceutical, or medical use due to lack of specificity and standardization, and should be updated to reference a specific, named molecule or receptor[1][4][5].